Key Points
-
TNFR-associated factors (TRAFs) constitute a family of seven cytoplasmic proteins that control signal transduction from different receptor families, including the tumour necrosis factor receptors (TNFRs), Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs). Therefore, TRAFs regulate various downstream signalling pathways, such as the nuclear factor-κB (NF-κB), mitogen-activated protein kinase (MAPK) and interferon regulatory factor (IRF) pathways, and control a plethora of biological functions, both in immune and non-immune cell types.
-
TRAFs share a similar domain organization. Receptors and other upstream proteins engage TRAFs typically via their carboxy-terminal TRAF domain, whereas the amino-terminal region promotes the synthesis of non-degradative K63-linked polyubiquitin chains, which are required for downstream signal transduction.
-
The function of TRAF3 remained unclear until recent studies demonstrated that it can perform at least three different molecular functions, depending on the engaging receptor and its interplay with other proteins, such as TRAF2, the E3 ubiquitin ligases cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2 and the protein kinase NF-κB-inducing kinase (NIK; also known as MAP3K14).
-
In TLR and RLR signalling pathways, TRAF3 is recruited into signalling complexes following pathogen encounter and acts as a ubiquitin ligase, promoting the synthesis of K63-linked polyubiquitin chains that control the activation of the type I interferon response. A patient with a destabilizing mutation in TRAF3 has been described who suffered from paediatric herpes simplex encephalitis, supporting the idea that TRAF3 functions in antiviral immune defence in humans.
-
Following the activation of certain TLRs and TNFRs (such as TLR4 and CD40), TRAF3 acts as a negative regulator, and its degradation is required for MAPK activation and the regulation of immune effector functions (for example, pro-inflammatory cytokine production). Receptor activation and the formation of a membrane-associated signalling complex leads to cIAP-mediated degradation of TRAF3, thereby liberating multiprotein complexes that contain MEK kinase 1 (MEKK1; also known as MAP3K1) and TGFβ-activated kinase 1 (TAK1; also known as MAP3K7) into the cytoplasm, where they activate downstream MAPK pathways.
-
Together with TRAF2 and cIAPs (and possibly other proteins), TRAF3 serves as a constitutive negative regulator of the alternative NF-κB pathway, which controls B cell survival and lymphoid organ development. Activation of a subset of TNFRs (including CD40, the BAFF receptor and the lymphotoxin-β receptor) results in cIAP-mediated TRAF3 degradation and the liberation of NIK, and this in turn leads to IκB kinase-α (IKKα)-mediated NF-κB activation. Mutations in several negative regulatory components in this pathway, including TRAF3, have been identified in cancer cells from patients with multiple myeloma, resulting in increased NF-κB activity and cancer cell survival.
Abstract
Tumour necrosis factor receptor (TNFR)-associated factor (TRAF) proteins are essential components of signalling pathways activated by TNFR or Toll-like receptor (TLR) family members. Acting alone or in combination, the seven known TRAFs control many biological processes, including cytokine production and cell survival. The function of one TRAF in particular, TRAF3, remained elusive for many years. Recent work has revealed that TRAF3 is a highly versatile regulator that positively controls type I interferon production, but negatively regulates mitogen-activated protein kinase activation and alternative nuclear factor-κB signalling. In this Review, we discuss our current understanding of the role of TRAF3 in TNFR and TLR signalling pathways, and its role in disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ha, H., Han, D. & Choi, Y. TRAF-mediated TNFR-family signaling. Curr. Protoc. Immunol. 87, 11.9D (2009).
Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 11, 373–384 (2010).
Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).
Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).
Zhu, S. et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207, 2647–2662 (2010).
Xie, P., Kraus, Z. J., Stunz, L. L., Liu, Y. & Bishop, G. A. TNF receptor-associated factor 3 is required for T cell-mediated immunity and TCR/CD28 signaling. J. Immunol. 186, 143–155 (2011).
Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681–692 (1994).
Xie, P., Hostager, B. S., Munroe, M. E., Moore, C. R. & Bishop, G. A. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling. J. Immunol. 176, 5388–5400 (2006).
Regnier, C. H. et al. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc. Natl Acad. Sci. USA 99, 5585–5590 (2002).
Shiels, H. et al. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. Am. J. Pathol. 157, 679–688 (2000).
Kalkan, T., Iwasaki, Y., Park, C. Y. & Thomsen, G. H. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-β signaling that affects neural crest formation. Mol. Biol. Cell 20, 3436–3450 (2009).
Baud, V. et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297–1308 (1999).
Liu, Z. G., Hsu, H., Goeddel, D. V. & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565–576 (1996).
Rothe, M., Sarma, V., Dixit, V. M. & Goeddel, D. V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424–1427 (1995).
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443–446 (1996).
Yamashita, M. et al. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol. Cell 31, 918–924 (2008).
Hacker, H. et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192, 595–600 (2000).
Hsu, H., Xiong, J. & Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495–504 (1995).
Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. & Cao, Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837–847 (1997).
Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. The TNFR2–TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243–1252 (1995).
Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G. & Wu, H. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation. Mol. Cell 38, 101–113 (2010).
Mace, P. D., Smits, C., Vaux, D. L., Silke, J. & Day, C. L. Asymmetric recruitment of cIAPs by TRAF2. J. Mol. Biol. 400, 8–15 (2010).
Vince, J. E. et al. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-κB and to prevent TNF-induced apoptosis. J. Biol. Chem. 284, 35906–35915 (2009).
Sanjo, H., Zajonc, D. M., Braden, R., Norris, P. S. & Ware, C. F. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-β receptor. J. Biol. Chem. 285, 17148–17155 (2010).
Bhoj, V. G. & Chen, Z. J. Ubiquitylation in innate and adaptive immunity. Nature 458, 430–437 (2009).
Chau, V. et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 243, 1576–1583 (1989).
Finley, D. et al. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol. 14, 5501–5509 (1994).
Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000).
Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351 (2001).
Xu, M., Skaug, B., Zeng, W. & Chen, Z. J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302–314 (2009).
Zeng, W., Xu, M., Liu, S., Sun, L. & Chen, Z. J. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36, 315–325 (2009).
Yamazaki, K. et al. Two mechanistically and temporally distinct NF-κB activation pathways in IL-1 signaling. Sci. Signal. 2, ra66 (2009).
Matsuzawa, A. et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663–668 (2008).
Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nature Immunol. 9, 1364–1370 (2008).
Yin, Q., Lamothe, B., Darnay, B. G. & Wu, H. Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48, 10558–10567 (2009).
Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297–303 (1998).
Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084–1088 (2010).
Wong, W. W. et al. RIPK1 is not essential for TNFR1-induced activation of NF-κB. Cell Death Differ. 17, 482–487 (2010).
Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831–844 (2009).
Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877–4887 (2006).
Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nature Cell Biol. 11, 123–132 (2009).
Tseng, P. H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunol. 11, 70–75 (2010).
Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37–40 (2001).
Gao, M. et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306, 271–275 (2004).
Karin, M. & Gallagher, E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol. Rev. 228, 225–240 (2009).
Yang, J. et al. Mekk3 is essential for early embryonic cardiovascular development. Nature Genet. 24, 309–313 (2000).
Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207 (2006).
Gohda, J., Matsumura, T. & Inoue, J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173, 2913–2917 (2004).
Gallagher, E. et al. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production. Nature Immunol. 8, 57–63 (2007).
Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nature Immunol. 6, 1087–1095 (2005).
Hacker, H. et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17, 6230–6240 (1998).
Kawai, T. & Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 1143, 1–20 (2008).
Kawai, T. et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol. 5, 1061–1068 (2004).
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640–643 (2003).
Marie, I., Durbin, J. E. & Levy, D. E. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660–6669 (1998).
Sato, M. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/βgene induction. Immunity 13, 539–548 (2000).
Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208–211 (2006).
Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693–733 (2009).
Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288 (2004).
Hauer, J. et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc. Natl Acad. Sci. USA 102, 2874–2879 (2005).
Hu, H. M., O'Rourke, K., Boguski, M. S. & Dixit, V. M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069–30072 (1994).
Cheng, G. et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494–1498 (1995).
Nakano, H. et al. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc. Natl Acad. Sci. USA 96, 9803–9808 (1999).
Hacker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13 (2006).
Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628–1632 (2007).
Saha, S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257–3263 (2006).
Paz, S. et al. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 4 Jan 2011 (doi: 10.1038/cr.2011.2).
Tang, E. D. & Wang, C. Y. MAVS self-association mediates antiviral innate immune signaling. J. Virol. 83, 3420–3428 (2009).
Nakhaei, P. et al. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog. 5, e1000650 (2009).
Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nature Immunol. 7, 962–970 (2006).
Ahmad-Nejad, P. et al. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958–1968 (2002).
Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nature Immunol. 9, 361–368 (2008).
Barton, G. M. & Kagan, J. C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nature Rev. Immunol. 9, 535–542 (2009).
Xiao, G., Fong, A. & Sun, S. C. Induction of p100 processing by NF-κB-inducing kinase involves docking IκB kinase α (IKKα) to p100 and IKKα-mediated phosphorylation. J. Biol. Chem. 279, 30099–30105 (2004).
Xiao, G., Harhaj, E. W. & Sun, S. C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7, 401–409 (2001).
Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nature Immunol. 3, 958–965 (2002).
Senftleben, U. et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293, 1495–1499 (2001).
Gardam, S., Sierro, F., Basten, A., Mackay, F. & Brink, R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391–401 (2008).
Xie, P., Stunz, L. L., Larison, K. D., Yang, B. & Bishop, G. A. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27, 253–267 (2007).
He, J. Q. et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency. J. Exp. Med. 203, 2413–2418 (2006).
Liao, G., Zhang, M., Harhaj, E. W. & Sun, S. C. Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279, 26243–26250 (2004).
Annunziata, C. M. et al. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115–130 (2007).
Keats, J. J. et al. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 12, 131–144 (2007).
Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669–681 (2007).
Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131, 682–693 (2007).
Zarnegar, B., Yamazaki, S., He, J. Q. & Cheng, G. Control of canonical NF-κB activation through the NIK–IKK complex pathway. Proc. Natl Acad. Sci. USA 105, 3503–3508 (2008).
Amir, R. E., Haecker, H., Karin, M. & Ciechanover, A. Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase. Oncogene 23, 2540–2547 (2004).
Perez de Diego, R. et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33, 400–411 (2010).
Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007).
He, J. Q., Saha, S. K., Kang, J. R., Zarnegar, B. & Cheng, G. Specificity of TRAF3 in its negative regulation of the noncanonical NF-κB pathway. J. Biol. Chem. 282, 3688–3694 (2007).
Ermolaeva, M. A. et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nature Immunol. 9, 1037–1046 (2008).
Chen, N. J. et al. Beyond tumor necrosis factor receptor: TRADD signaling in Toll-like receptors. Proc. Natl Acad. Sci. USA 105, 12429–12434 (2008).
Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621–663 (2000).
Acknowledgements
We thank P. Mehta for the bioinformatics analysis of the TRAF domain structures depicted in Fig. 1. H.H. was supported by US National Institutes of Health (NIH) grant AI083443 and the American Lebanese Syrian Associated Charities (ALSAC). Work was also supported by NIH grant AI043477 to M.K., who is an American Cancer Society Research Professor.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- Inhibitor of apoptosis
-
A class of proteins (cIAP1, cIAP2, XIAP and NAIP) that contain BIR domains and that can act under certain conditions as intracellular caspase inhibitors. For cIAP1 and cIAP2 function in TNFR-associated factor (TRAF)-dependent signal transduction pathways, this function is probably not relevant.
- E3 ubiquitin ligases
-
Enzymes that attach ubiquitin to substrate proteins. Single-subunit E3 ubiquitin ligases contain both the substrate-binding domain(s) and E2 tranferase recruitment machinery in the same polypeptide chain, whereas multisubunit E3 ubiquitin ligases divide these functions between individual protein components. E3 ubiquitin ligases are further classified on the basis of their E2 transferase recruitment domains, which can be HECT-type, RING finger-type or U box-type.
- Mitogen-activated protein kinase
-
(MAPK). MAPKs are a group of serine/threonine-specific protein kinases that are activated by a variety of stimuli, including growth factors, cytokines, ionizing radiation and osmotic shock. MAPK activation is controlled through defined kinase cascades, which include a MAPK kinase (MAPKK) and a MAPKK kinase (MAP3K). These MAPK cascades serve as information relays, connecting different sensor molecules (such as cell surface receptors) to specific regulatory proteins (including transcription factors), thereby translating changes in the cell environment into gene regulation.
- Alternative NF-κB pathway
-
A nuclear factor-κB (NF-κB) activation pathway that is activated by a subset of TNF receptor family members, including BAFFR, LTβR and CD40. In contrast to the classic NF-κB pathway, which depends on the catalytic activity of IκB kinase-β (IKKβ), the alternative pathway depends on the catalytic activity of IKKα, which phosphorylates p100 (also known as NF-κB2). This results in limited proteolytic processing of the C-terminal part of p100, thereby liberating the N-terminal active transcription factor p52. p52, together with its dimerization partner RELB, enters the nucleus and drives transcription.
- Ubiquitylation
-
The attachment of the small protein ubiquitin to (primarily) lysine residues in other proteins. Protein ubiquitylation occurs in three enzymatic steps requiring a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2) and a ubiquitin ligase (E3), which catalyses the ligation of an isopeptide bond between the C terminus of ubiquitin and an amino group belonging to a lysine residue of the target protein.
- Proteasome
-
A giant multicatalytic protease resident in the cytosol and the nucleus. The 20S core, which contains three distinct catalytic subunits, can be appended at either end by a 19S cap or an 11S cap. The binding of two 19S caps to the 20S core forms the 26S proteasome, which degrades polyubiquitylated proteins.
- Plasmacytoid dendritic cells
-
(pDCs). A subset of DCs that are described as plasmacytoid because their microscopic appearance resembles that of plasmablasts. On a per cell basis, pDCs are the main producers of type I interferons in response to virus infections or Toll-like receptor stimulation.
- Plasma cells
-
Non-dividing, terminally differentiated, immunoglobulin-secreting cells of the B cell lineage.
- SCFβTrCP
-
A multiprotein complex containing a protein core of SKP1, CUL1 and an F-box protein (the SCF complex) that catalyses the ubiquitylation of specific proteins destined for proteasomal degradation. β-transducin repeat-containing protein (βTrCP) is an F-box protein that recognizes specific phosphorylated substrates, including NK-κB inhibitor-α (IκBα) and p100 (also known as NK-κB2).
- Herpes simplex encephalitis
-
Herpes simplex encephalitis is a rare complication of herpes simplex virus 1 (HSV-1) infection and has been associated with the impairment of innate immunity to HSV-1.
Rights and permissions
About this article
Cite this article
Häcker, H., Tseng, PH. & Karin, M. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol 11, 457–468 (2011). https://doi.org/10.1038/nri2998
Published:
Issue Date:
DOI: https://doi.org/10.1038/nri2998
This article is cited by
-
Targeted inhibition of PTPN22 is a novel approach to alleviate osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice
BMC Medicine (2023)
-
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer
Journal of Experimental & Clinical Cancer Research (2023)
-
Effects of TRAF3 on the proliferation and migration of lung adenocarcinoma depend partly on pyroptosis
BMC Cancer (2023)
-
TMT-based quantitative proteomics reveals the targets of andrographolide on LPS-induced liver injury
BMC Veterinary Research (2023)
-
Stony coral tissue loss disease induces transcriptional signatures of in situ degradation of dysfunctional Symbiodiniaceae
Nature Communications (2023)